Strong Vaccine Support Amid Trump’s Negative Ratings

Industry Insights from Next Move Strategy Consulting

As the U.S. navigates complex debates over tariffs, immigration, and public health, a new CNBC News Decision Desk Poll powered by SurveyMonkey reveals that Americans remain deeply divided over President Donald Trump’s performance. Yet, within these divisions, one issue stands out with striking clarity: strong bipartisan support for vaccines.

Approval Ratings Under Pressure

Immigration presents a more nuanced picture: 47% approve when asked about “border security and immigration,” but approval slips to 43% when the wording includes “deportations,” reflecting divisions over the administration’s aggressive policies.

The Intensity of Public Opinion

Beyond approval metrics, the poll measures intensity of sentiment. Nearly half of Democrats (49%) describe themselves as “furious” with the administration’s actions, while 27% of Republicans say they are “thrilled.” Independent voters lean sharply negative, with only 8% expressing positive views and a majority clustering around “neutral” or “dissatisfied.”

Such polarized intensity signals that voter enthusiasm will play a critical role in shaping upcoming elections, especially with midterms on the horizon.

Industry Outlook

According to Next Move Strategy Consulting, the NBC News Decision Desk Poll sends a strong market signal: bipartisan support for vaccines remains a key public priority, despite the broader political divide. With over 90% of Democrats, 72% of independents, and 67% of Republicans expressing support for vaccines, the findings suggest reinforced consumer trust and demand in the vaccine market.

This public sentiment is likely to drive vaccine manufacturers and distributors to accelerate efforts in expanding production, improving supply chain efficiency, and developing next-generation vaccine formulations. Furthermore, the industry faces increasing pressure to resist restrictive policy moves and to advocate for science-based regulatory frameworks that ensure vaccine access remains broad and equitable.

It emphasizes that policymakers will also need to consider this strong public consensus when shaping future public health strategies. The survey indicates that vaccine market growth will not only remain stable but could accelerate, as consumer and institutional demand is expected to rise in line with public expectations for accessible, effective vaccination solutions.

Defining the Policy Landscape Ahead

As Trump’s administration pushes sweeping changes and faces scrutiny over economic and immigration performance, the enduring bipartisan support for vaccines stands as a clear marker of public priorities. In a climate defined by polarization, the strong consensus around vaccines may influence both legislative outcomes and industry responses in the months ahead.

Source: CNBC News

Prepared by: Next Move Strategy Consulting